CVC Capital Partners
IPO offers CVC chance to become multi-asset consolidator
Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl
CVC raises Europe’s largest ever buyout fund, securing EUR 26bn for ninth vehicle
Fund was launched in January 2023 and surpassed its EUR 25bn target, the GP said in a statement
CVC Credit targets EUR 7bn for new European direct lending fund
Fresh fundraise follows the EUR 6.3bn final close for the strategy's predecessor vehicle in December 2022
Slice of pie: New entrants gobble up GP stakes in Europe
Armen, Hunter Point Capital, GP House and Axa IM rustle up new minority investments, as Inflexion and Coller sell
Germany’s DFL to collect NBOs for EUR 3bn media rights stake
Large-cap sponsors including Advent, Blackstone, Bridgepoint, CVC, EQT and KKR expected to bid today
Wellspect bidders CVC, KKR, PAI, EQT expected to progress into second round
US trade owner attempted a previous sale for the Swedish bladder and bowel-control products specialist in 2018
PE roll-up strategies face regulatory heat with focus on consumer industries
With longer holding periods facilitating more bolt-ons, regulators including the UK's CMA are intervening
Eurazeo's Groupe Premium attracts multiple PE bidders ahead of IMs
Insurance broker has seen interest from parties including Ardian, Bridgepoint, BC Partners, Cinven, CVC
CVC acquires Scan Global logistics from AEA Investors
AEA and management have reinvested for a minority stake in the Danish logistics provider
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons
Going, going, not gone: PE auctions bid for relevance amid risk-off environment
With a debt financing drought and macro woes denting exits, GPs are adapting the traditional M&A auction in favour of more flexible bilateral negotiations to get deals across the line
Dyal raises USD 12.9bn for new fund with CVC, PAI stakes in portfolio
Blue Owl’s division exceeded target for fifth fund specialised in buying minority stakes in asset managers
The Bolt-Ons Digest – 14 December 2022
Unquote’s selection of the latest add-ons, including CVC's Stark Group, Bridgepoint's Kereis, EQT's Open Systems, and more
CVC weighs strategic options for IT training provider QA
GP in informal discussions around exit or sale of parts of the UK-based company
KKR invests in CVC's French insurer April Group
US sponsor to become new majority owner; company achieved its objectives more than a year in advance
Haul of large funds closings in Q1 2023 clouds new managers outlook – conference
Good news is drop in valuations could feed good vintages in the coming years, participants at SuperInvestor tell Unquote
Final close: Sponsors fight through buyout fundraising drought
With EUR 100.5bn in commitments this year, European buyout fundraising is likely to be the lowest since 2018
Jewson carve-out sees Apollo, CVC, HIG, TDR in round two
Final bids for Saint-Gobain's building materials unit are due at the end of this month
CVC discards Mehiläinen exit options, focuses on growth
GP bought the Finland-based healthcare service provider in EUR 1.8bn SBO from KKR in 2018
Sika draws sponsor interest in sale of MBCC assets
Chemicals company aims to address regulatory concerns over acquisition of German peer MBCC
The Bolt-Ons Digest – 17 October 2022
Unquote’s selection of the latest add-ons with Equistone's Ligentia, Bridgepoint's Infinigate, Ambienta’s Namirial and more
Sponsors brave the storm amid drop in financial services M&A
GP buyouts in the financial services space reached a two-year high in H1 2022 as rising financing costs and a brewing recession cloud the sector's M&A outlook
The Bolts-Ons Digest – 17 June 2022
Unquote’s selection of the latest add-ons with Holland's AMP, Triton's Kinios, Nordic's Sortera, Vitruvian's Sykes, and more
HG-backed Visma to divest IT consulting unit to CVC
Sponsor will invest in the carve-out from the Norwegian business software and IT provider via Fund VIII